A prospective, single-centre, single-arm, unmasked, First in Human study that aims to evaluate the safety and efficacy of SakuraBead resorbable microspheres in adult patients suffering from pain secondary to knee osteoarthritis.
To evaluate safety and efficacy of SakuraBead for the treatment of pain secondary to knee osteoarthritis. Treatment will be performed on up to 15 patients who will be followed up for a period of 6 months.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Temporary Embolization of Genicular Arteries using SakuraBead Resorbable Microspheres
The Republican Specialized Scientific and Practical Medical Center of Therapy and Medical Rehabilitation
Tashkent, Uzbekistan
Decrease of pain on Visual Analogue Scale (VAS) at 1 month follow-up.
Time frame: 1 month
Genicular Artery Embolization (GAE) without a major device- or procedure-related complication at 1 month follow-up
Time frame: 1 month
Reduction in global Western Ontario and McMaster University Osteoarthritis Index (WOMAC) questionnaire at 1 month, 3 months and 6 months follow-up
Time frame: 1, 3 and 6 months
Reduction of previously initiated OsteoArthritis (OA) medical therapy at 3- and 6-months follow-up
Time frame: 3 and 6 months
Decrease of pain on Visual Analogue Scale (VAS) at 3 and 6 months
Time frame: 3 and 6 months
No major device- or procedure-related complication at 3 and 6 months
Time frame: 3 and 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.